An integrated electrochemical platform based on Ti3C2-AgNPs and 3D-printed microfluidics for simultaneous detection of PSA and PSMA
Microchimica Acta · 2026
DOI: 10.1007/s00604-026-07838-6 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microchimica Acta, 2026. Verfasst von Song-Song Yang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of printing and packaging, Beijing Institute of Graphic Communication, Beijing, 102600, China. Hauptthemen laut MEDLINE: Prostate-Specific Antigen, Titanium, Electrochemical Techniques, Metal Nanoparticles. Die Arbeit nennt 53 Literaturangaben. Gefördert von: 2024 Capital's Funds for Health Improvement and Research-Application of holographic three-dimensional imaging technology in partial nephrectomy of renal tumors, the National Natural Science Foundation of China, 2024 Capital’s Funds for Health Improvement and Research-Application of holographic three-dimensional imaging technology in partial nephrectomy of renal tumors.
Abstract (Originalsprache)
A dual-channel label-free electrochemical immunosensing platform is proposed based on a 3D-printed microfluidic architecture and Ti3C2-AgNPs composite material, achieving synergistic innovation in structural design and material engineering. Structurally, stereolithography (SLA) 3D printing constructs a spatially separated dual-chamber microfluidic array integrated with screen-printed electrodes. This design enables independent liquid transport and electrical signal isolation across different analytical channels, fundamentally suppressing signal crosstalk during multi-target detection. To achieve high sensitivity, the electrode surfaces were modified with a novel Ti3C2-AgNPs nanocomposite that significantly enhances charge transfer kinetics by preventing Ti3C2 nanosheet aggregation through modulation of AgNPs interlayer spacing. This integrated platform was validated through the simultaneous quantification of two critical prostate cancer (PCa) biomarkers, prostate-specific antigen (PSA) and prostate-specific membrane antigen (PSMA). This immunosensor mitigates signal crosstalk whilst exhibiting superior analytical performance, with a linear range of 0.1–1,000 ng mL⁻¹, sensitivity of 0.0036 µA mL ng⁻¹ for PSA and 0.0024 µA mL ng⁻¹ for PSMA, and detection limits of 0.045 ng mL⁻¹ for PSA and 0.041 ng mL⁻¹ for PSMA. Furthermore, this device exhibited exceptional repeatability, stability, and specificity. Clinical validation using human serum samples exhibited strong concordance with clinical reference methods, enabling precise discrimination between PCa patients and healthy controls. Consequently, the proposed dual-channel label-free electrochemical immunosensors (EIs), based on Ti3C2-AgNPs nanocomposites, holds substantial promise for clinical diagnostic applications, with potential for expansion to the ultrasensitive detection of other disease-related biomarkers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of printing and packaging, Beijing Institute of Graphic Communication, Beijing, 102600, China.
- Department of printing and packaging, Beijing Institute of Graphic Communication, Beijing, 102600, China. hanlu@iccas.ac.cn.
- Department of urology, Peking university shougang hospital, Beijing, 100144, China. wanglei_09243633@163.com.
- Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, 100091, China. drliupeng@sina.cn.
Förderung
- 2024 Capital's Funds for Health Improvement and Research-Application of holographic three-dimensional imaging technology in partial nephrectomy of renal tumors
- the National Natural Science Foundation of China
- 2024 Capital’s Funds for Health Improvement and Research-Application of holographic three-dimensional imaging technology in partial nephrectomy of renal tumors
Zitieren
APA
Yang, S. S., Xin, W. L., Zhang, K., Han, L., Cai, H. Q., Xue, X. Y., Sun, Z. C., Hu, K., Wang, L., & Liu, P. (2026). An integrated electrochemical platform based on Ti3C2-AgNPs and 3D-printed microfluidics for simultaneous detection of PSA and PSMA. Microchimica Acta. https://doi.org/10.1007/s00604-026-07838-6
Vancouver
Yang SS, Xin WL, Zhang K, Han L, Cai HQ, Xue XY, et al. An integrated electrochemical platform based on Ti3C2-AgNPs and 3D-printed microfluidics for simultaneous detection of PSA and PSMA. Microchimica Acta. 2026. doi:10.1007/s00604-026-07838-6
BibTeX
@article{Yang2026,
author = {Yang, Song-Song and Xin, Wu-Lin and Zhang, Kou and Han, Lu and Cai, He-Qing and Xue, Xin-Yu and Sun, Zhi-Cheng and Hu, Kun and Wang, Lei and Liu, Peng},
title = {An integrated electrochemical platform based on Ti3C2-AgNPs and 3D-printed microfluidics for simultaneous detection of PSA and PSMA},
journal = {Microchimica Acta},
year = {2026},
doi = {10.1007/s00604-026-07838-6}
}
EUVIMED